Related Experiment Video
Updated: Feb 13, 2026

14:10
Characterizing Salmonella Typhimurium-induced Septic Peritonitis in Mice
Published on: July 29, 2022
5.9K
[Acute blood purification for septic multiple organ failure]
1Hyogo Emergency Medical Center.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|December 16, 2004
Summary
Blood purification methods like continuous renal replacement therapy (CRRT) and direct hemoperfusion with polymyxin B immobilized fiber (PMX-DHP) can treat septic multiple organ failure (MOF). Choosing the right blood purification depends on the specific causes of MOF.
Area of Science:
- Critical Care Medicine
- Nephrology
- Sepsis Pathophysiology
Background:
- Blood purification is crucial for managing septic multiple organ failure (MOF).
- Continuous renal replacement therapy (CRRT) aids in fluid, electrolyte, and acid-base balance, and waste removal.
- Continuous plasma exchange (CPE) with CRRT serves as artificial liver support for septic hepatic failure.
Purpose of the Study:
- To review the applications of various blood purification techniques in treating septic MOF.
- To highlight the role of direct hemoperfusion with polymyxin B immobilized fiber (PMX-DHP) in improving circulation and reducing cytokines.
- To emphasize the importance of matching blood purification strategies to the underlying causes of MOF.
Main Methods:
- Review of existing literature on blood purification in septic MOF.
- Discussion of continuous renal replacement therapy (CRRT) and continuous plasma exchange (CPE).
- Examination of direct hemoperfusion with polymyxin B immobilized fiber (PMX-DHP) and its proposed mechanism involving endogenous cannabinoid adsorption.
Main Results:
- CRRT effectively manages physiological balance and waste products in MOF.
- CPE combined with CRRT offers support for septic hepatic failure.
- PMX-DHP demonstrates rapid improvements in circulation and reduced cytokine levels, potentially via cannabinoid adsorption.
Conclusions:
- The choice of blood purification for septic MOF should be guided by the specific pathophysiological causes.
- A combination of therapies may be necessary for comprehensive management.
- Further research into mechanisms like cannabinoid adsorption by PMX-DHP is warranted.
Related Concept Videos
Acute Respiratory Failure-I
1.1K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
Acute Respiratory Failure-II
1.2K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K
Acute Respiratory Failure-V
515
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
515
Acute Respiratory Failure-III
943
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
943
Acute Respiratory Failure-IV
578
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
578
Multiple Allele Traits
38.2K
The Concept of Multiple Allelism
38.2K

